TickerFacts.

PMV Pharmaceuticals, Inc. (PMVP): Cash & Equivalents

Annual figures by period end, from SEC filings.

$37.98M
As of 2025-12-31
$12.47M
As of 2026-06-30
-29.5%
3-year compound annual growth
-36.3%
5-year compound annual growth
$361.42M2019-12-31: $73.28M2020-12-31: $361.42M2021-12-31: $172.47M2022-12-31: $108.30M2023-12-31: $37.71M2024-12-31: $40.88M2025-12-31: $37.98M$37.98M
2019-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$37.98M-7.1%2026-03-06, Balance as of period end
2024-12-31$40.88M+8.4%2026-03-06, Balance as of period end
2023-12-31$37.71M-65.2%2025-03-03, Balance as of period end
2022-12-31$108.30M-37.2%2024-02-29, Balance as of period end
2021-12-31$172.47M-52.3%2023-03-01, Balance as of period end
2020-12-31$361.42M+393.2%2022-03-01, Balance as of period end
2019-12-31$73.28Mn/a2021-03-03, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
PMV Pharmaceuticals, Inc. (PMVP)2025-12-31$37.98M-7.1%
Sagimet Biosciences Inc. (SGMT)2025-12-31$35.02M-53.8%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$15.86M-88.2%
Aardvark Therapeutics, Inc. (AARD)2025-12-31$47.05M-23.7%
Camp4 Therapeutics Corp (CAMP)2025-12-31$109.52M+71.0%
Filana Therapeutics, Inc. (FLNA)2025-12-31$95.50M-25.7%
Rafael Holdings, Inc. (RFL)2025-07-31$52.77Mn/m
Kyntra Bio, Inc. (KYNB)2025-12-31$47.87M-5.2%
Milestone Pharmaceuticals Inc. (MIST)2025-12-31$73.05M+188.6%

Compare PMVP, SGMT, AVTX, AARD side by side · Screen every company in Pharmaceutical Preparations ↗